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Dystrophic epidermolysis bullosa (DEB) is a group
of hereditary mechanobullous disorders charac-
terized by blistering and scarring of the skin and
mucosae and nail dystrophy induced by minor
trauma.1,2 Blisters occur below the basement
membrane zone at the level of anchoring fibrils.
The fragility of the skin or mucous membranes is
attributed to morphologic alteration, scarcity, or
even the complete absence of anchoring fibrils, the
attachment structures extending from the base-
ment membrane zone to the underlying dermis.3
Anchoring fibrils are composed predominantly
of type VII collagen, a homotrimer consisting of
three identical proα1 (VII) chains.4
Both dominant and recessive DEB have been
linked to COL7A1, and over 242 pathogenic mu-
tations have been detected within COL7A1 in
different variants of DEB.5 The vast majority of
these mutations were specific to individual DEB
families, with only a few recurrent mutations 
reported.5,6
Despite the considerable phenotypic varia-
tion in DEB, certain correlations between geno-
types and phenotypes have been suggested.7
Premature termination codon (PTC) mutations
in both COL7A1 alleles are found in the majority
of cases with severe, Hallopeau-Siemens type of
recessive DEB (HS-RDEB), which is characterized
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Dystrophic epidermolysis bullosa (DEB) is a hereditary mechanobullous disorder characterized by fragility
of the skin and mucous membranes caused by abnormal anchoring fibrils. Both dominant and recessive
DEB are caused by mutations in COL7A1, the gene encoding type VII collagen, the major component of 
anchoring fibrils. We performed mutation analysis of COL7A1 in three patients with recessive DEB. The
diagnosis of DEB was based on the characteristic clinical features and confirmed histopathologically. All
118 exons and flanking intron boundaries of COL7A1 were amplified. Four novel mutations (3373insGG,
7769delG, E1535X, G2061E) and two potential splicing mutations were detected. The first three of these
mutations resulted in premature termination codons, while G2061E caused a glycine substitution mutation
in the triple-helical domain. This is the first report of mutation analyses of the COL7A1 gene in Taiwanese
pedigrees with recessive DEB. Each patient had a heterozygous premature termination codon mutation
combined with either a glycine substitution mutation in the critical triple-helical collagenous domain or
a potential splicing mutation. These genotypes correlate well with the severe clinical phenotype of recessive
DEB. [J Formos Med Assoc 2007;106(1):86–91]
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by mutilating scarring of the skin and complete
absence of anchoring fibrils. Such mutations result
in the inability of truncated type VII collagen poly-
peptides to assemble into functional anchoring
fibrils.8 On the contrary, the milder mitis form 
of recessive DEB is usually caused by missense
mutations or an in-frame deletion in one or both
alleles; these mutations are less disruptive to the
protein.9,10 In this study, we performed mutation
analysis of three Taiwanese families with severe
recessive DEB.
Patients and Methods
Patients
Three patients with a diagnosis of severe DEB made
in our department were recruited. Each patient had
presented at birth with recurrent, widespread blis-
ters over the whole body, including the oral mu-
cosa, resulting in ulceration and scarring with
mutilation of the hands and feet (Figure 1). Histo-
pathology showed subepidermal blisters with
fibrosis of the upper dermis. The anchoring fibrils
Figure 1. (A, B) Severe dystrophic 
epidermolysis bullosa in Patient 1.
Extensive ulceration and scarring with
severe mutilation of the hands and feet
caused by chronic recurrent blistering.
(C, D) Widespread scarring with 
ulceration of the extremities and partial
fusion of the fingers in Patient 2.
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were poorly formed and markedly reduced in
number ultrastructurally (Figure 2), confirming the
diagnosis of DEB. Patient 3 had a younger brother
with a similar condition. The parents in each family
were unrelated and clinically unaffected.
PCR amplification and heteroduplex 
analyses
Genomic DNA was extracted from peripheral
blood collected from the proband and other
members of the family after obtaining informed
consent. DNA samples were subjected to mutation
screening by amplifying segments of COL7A1
spanning all 118 exons of the gene using primers
synthesized on the basis of intronic sequences
(GenBank L23982).11 The PCR products were ex-
amined on 2% agarose gel and 3–10μL of the sam-
ples were prepared for heteroduplex analysis using
conformation-sensitive gel electrophoresis (CSGE)
as described previously.12 The PCR products that
demonstrated shifted bands were subjected to
directed automated sequencing (ABI Advanced
Biotechnologies, Columbia, MD, USA).
Results
Patient 1
CSGE of the PCR products of exons 25, 103 and
104 revealed distinct heteroduplex patterns in
the proband’s DNA. Direct DNA sequencing of the
PCR products from the proband and mother
showed a heterozygous PTC mutation of 3373ins
GG within exon 25, and from the proband and
father showed a heterozygous PTC mutation of
7769delG within exon 104 (Figure 3). Both mu-
tations are predicted to cause frame shifts and
create downstream stop codons, resulting in a
prematurely truncated and nonfunctional pro-
tein product (Table).
Patient 2
CSGE of the PCR products of exons 44–46 and
113 revealed distinct heteroduplex patterns in
the proband’s DNA. Direct DNA sequencing of
the PCR products from the proband and father
showed a heterozygous G-to-T transition at nu-
cleotide 4603 within exon 46. The substitution
converted a glutamine (GAG) to a stop codon
(TAG) (E1535X). A heterozygous G-to-C transi-
tion was detected at nucleotide 8407 + 5 within
intron 113 (Table). This mutation may poten-
tially affect splicing.
Patient 3
CSGE of the PCR products of exons 74, 75 and 116
revealed distinct heteroduplex patterns in the
proband’s DNA (Table). Direct DNA sequencing
of the PCR products from the proband and father
showed a heterozygous G-to-A transition at nu-
cleotide 6182 within exon 74. The substitution
converted a glycine (GGA) to a glutamine (GAA).
This missense mutation (G2061E) was confirmed
by the loss of an MboII restriction site. Using MboII
to digest the 370-bp PCR products revealed two
bands (351 bp and 19 bp) in the healthy controls
(200 alleles from 100 healthy unrelated controls).
Digestion of the proband’s DNA showed a 370-bp
band in addition to 351-bp and 19-bp bands, in-
dicating heterozygosity for this mutation. These
findings suggest that G2061E is not a common
polymorphism and was, in fact, a pathogenic
mutation specific to this family. A heterozygous
G-to-A transition was also detected at nucleotide
8620 + 26 within intron 116. This mutation may
potentially affect splicing.
Figure 2. Electron micrograph shows that the anchoring fib-
rils (arrowheads) are poorly formed and markedly reduced in
number ultrastructurally. Bar=500nm. (Patient 2, 25,000×).
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Figure 3. (A) An insertion mutation (3373insGG)
was detected in exon 25 using direct DNA 
sequencing in Patient 1 and his mother. 
(B) Normal sequence of exon 25 from the father. 
(C) A deletion mutation (7769delG) is detected 
in exon 104 using direct DNA sequencing in 
Patient 1 and his father. (D) Normal sequence of
exon 104 from the mother.
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Table. COL7A1 mutations in patients with recessive dystrophic epidermolysis bullosa
Patient Sex Parent Location Mutation* Nucleotide change† Consequence
1 Male Father Exon 104 Deletion 7769delG Frameshift and PTC
Mother Exon 25 Insertion 3373insGG Frameshift and PTC
2 Female Father Exon 46 E4603X 4603GT PTC
Mother Exon 113 8407 + 5 gc Splice site‡
3 Male Father Exon 74 G2061E 6182GA Missense
Mother Exon 116 8620 + 26 ga Splice site‡
*Numbering of the amino acids to the peptide sequence; †numbering of the nucleotides refers to COL7A1 cDNA sequence, with the first
nucleotide of the ATG initiation codon being 1, bases in exons are denoted by uppercase letters and bases in introns by lowercase letters;
‡this mutation may potentially affect splicing. PTC = premature termination codon.
Discussion
The present study of mutation analyses in three
Taiwanese pedigrees with severe recessive DEB
detected four novel mutations (3 PTCs and 1
missense mutation) as well as two potential
splicing mutations in the COL7A1 gene. Prior
studies showed that genetic defects consisting of
PTCs in both COL7A1 alleles resulted in truncated
type VII collagen polypeptides that were unable
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to assemble into functional anchoring fibrils.
Three of the mutations (3373insGG, 7769delG,
E1535X) detected in the present study are predic-
ted to cause prematurely truncated and nonfunc-
tional protein products.8 The missense mutation
G2061E replaces a glycine residue in the collage-
nous subdomain with Gly-X-Y repeats and may
cause instability of the critical triple-helical con-
formation of the collagenous domain. Based on
the observation of good preservation of the posi-
tions of the imperfections and interruptions in the
type VII collagen through evolution, a previous 
report suggested that the stability of the triple-
helical segment adjacent to the unstable nonheli-
cal interruption is critical for the function of type
VII collagen.13 As more and more COL7A1 muta-
tions have been delineated, it appears that this
hypothesis is correct. The distribution of 97
COL7A1 mutations along the type VII collagen
polypeptide has been depicted,7 and most of 
the mutations in dominant DEB involve glycine
substitution in the triple-helical domains. Inter-
estingly, half of the 26 such mutations (from
G1982W to G2079E) cluster immediately down-
stream from the noncollagenous “hinge” region.14
The G2061E mutation detected in our pedigree 3
was 83 amino acids downstream from the major
39-amino acid noncollagenous hinge region in
the collagenous domain. Mutation analyses in the
present study revealed a heterozygous PTC muta-
tion in each case combined with either a glycine
substitution mutation in the critical triple-helical
conformation of the collagenous domain or poten-
tial splicing mutation. Unfortunately, RNA was not
available for further confirmation. These geno-
types correlate well with the severe clinical pheno-
type of recessive DEB.
Although mutation analyses have been report-
ed previously in Taiwanese patients with other
types of epidermolysis bullosa,15–20 this is the
first report of a mutation analysis of recessive
DEB in Taiwan. The genetic confirmation of mu-
tation in DEB provides crucial information for
genetic counseling, especially for families with
severe DEB.
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